Akebia Therapeutics

+$0.09 (+2.81%) Today
$0.00 (0.00%) As of 9:01 PM UTC after-hours

Why Robinhood?

You can buy or sell AKBA and other stocks, options, and ETFs commission-free!

About AKBA

Akebia Therapeutics, Inc. Common Stock, also called Akebia Therapeutics, is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease.

CEO
John P. Butler
Employees
379
Headquarters
Cambridge, Massachusetts
Founded
2007

AKBA Key Statistics

Market Cap
512.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.80M
High Today
$3.44
Low Today
$3.11
Open Price
$3.11
Volume
3.06M
52 Week High
$13.71
52 Week Low
$2.09

AKBA Earnings

-$0.79
-$0.58
-$0.38
-$0.17
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.36 per share
Actual
-$0.45 per share
Replay Earnings Call

You May Also Like

CDR-C
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure